logo_biomaplanmed

BiomaPlan® MED is a test for the evaluation of the intestinal microbiota which involves the genetic analysis of bacterial DNA< /7> present in the client's fecal sample, followed by a bioinformatics analysis of the data and a microbiological evaluation, and accompanied by taxonomy information.

LOGIN
image_header
dna_helix

Useful for Personalized Probiotic Therapies

In particular:
  • biomaplanmedicon

    In the presence of digestive system pathologies, dyspepsia, gastritis, reflux, peptic ulcer, H. pylori, abdominal swelling and painful tension, IBD, irritable bowel syndrome, diverticular disease, candidiasis.

  • biomaplanmedicon

    Onset and/or persistence of intestinal or urogenital disorders (colitis, recurrent diarrhea, constipation, alternate bowel movements, cystitis, urethritis, etc.

  • biomaplanmedicon

    In the presence of obesity or overweight, metabolic syndrome.

  • biomaplanmedicon

    To limit typical aging phenomena such as immune depression.

  • biomaplanmedicon

    To address the metabolic and hormonal changes of menopause.

  • biomaplanmedicon

    In the presence of chronic inflammation.

  • biomaplanmedicon

    In case of chronic drug therapy (PPI, Metformin, NSAIDs, antibiotics, chemotherapy).

dna_helix

All the advantages of BiomaPlan® MED

  • biomaplanmedicon

    Report integrated with the clinical history of the patient thanks to a medical history questionnaire.

  • biomaplanmedicon

    Easy interpretation report.

  • biomaplanmedicon

    Taxonomic table with AVS count and relative abundance of detected bacterial species.

  • biomaplanmedicon

    Targeted therapeutic possibilities.

  • biomaplanmedicon

    Scientific collaboration with Unifarco, a Belluno pharmaceutical company.

Hi, do you need more information?
The following questions have been reported to improve the purchasing and using experience of BiomaPlan® MED.